Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PL-5 Spray for Wound Infection
CTR20192625Phase 2Completed
- Sponsor
- Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.
- Start
- Dec 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of peceleganan in Wound infection (WI), sponsored by Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.. Started Dec 2019; status: completed.
02
Drugs
peceleganan
03
Conditions
Wound infection (WI)
Beyond the preview
Go deeper on CTR20192625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192625.